32 studies found for:    " June 24, 2009":" July 24, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Recruiting Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis
Conditions: HIV Infection;   Pulmonary TB
Intervention: Drug: ATT (Ethambutol, Pyrazinamide, INH, Rifampicin)
22 Active, not recruiting Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Drug: efavirenz/emtricitabin/tenofovir;   Drug: lopinavir/ritonavir
23 Unknown  Simplification From Protease Inhibitors to Raltegravir
Condition: HIV Infections
Intervention: Drug: Raltegravir (Use RAL as a simplification strategy)
24 Completed Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761;   Drug: Lopinavir/ritonavir;   Drug: HAART;   Drug: Placebo
25 Active, not recruiting
Has Results
A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572 (Cohort I);   Drug: GSK1349572 (Cohort II)
26 No longer available An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Condition: HIV Infections
Intervention: Drug: Tipranavir
27 Completed
Has Results
A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: 2N(t)RTI;   Drug: Ritonavir-boosted lopinavir
28 Completed Drug Interaction Study Between Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers
Conditions: HIV;   Asthma
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: Beclomethasone Dipropionate HFA
29 Completed
Has Results
Evaluation of Diagnostic HIV Ag/Ab Combo Assay
Condition: Human Immunodeficiency Viruses
Intervention: Device: ARCHITECT HIV Ag/Ab Combo
30 Completed
Has Results
BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.
Condition: HIV
Interventions: Drug: atazanavir/raltegravir;   Drug: atazanavir/tenofovir/emtricitabine
31 Completed GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study
Condition: Healthy Volunteer
Interventions: Drug: GSK1349572;   Drug: Placebo;   Drug: Omeprazole
32 Completed The Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: Lersivirine;   Drug: Placebo;   Drug: Lersivirine (if necessary);   Drug: Moxifloxacin

Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page
Indicates status has not been verified in more than two years